do you have to take glp 1 for life people with obesity need a GLP-1 the rest of their life? Which GLP-1 weight loss drugs
Description
For comparison of means the MannWhitney- U Test was applied

Compared with patients without diabetes, patients with diabetes have a 2fourfold higher risk of atherosclerotic cardiovascular diseases (ASCVD), including coronary artery disease, stroke, and peripheral artery disease [1]

Peer-reviewed literature on ipamorelin from 2020 to 2026 is limited, with only 8 high-quality studies identified via PubMed searches (primarily preclinical or small human trials)

Conclusions As our understanding of obesity and the associated hormonal changes continues to improve, further drug developments and therapies will be introduced

Genetic and biased agonist-mediated reductions in -Arrestin recruitment prolong cAMP signaling at glucagon family receptors
